Indications and rationale for the use of proteinase inhibitors in obstetrics.
D000818:Animals; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007611:Aprotinin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D002364:Caseins / Q000037:antagonists & inhibitors; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011817:Rabbits; D014361:Trypsin Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D002364:Caseins; D014361:Trypsin Inhibitors; D007611:Aprotinin